Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nature’s Youth Supplement Relabeled Without Growth Factor Reference

This article was originally published in The Tan Sheet

Executive Summary

Marketing of Nature's Youth dietary supplement has resumed in packaging that no longer refers to human growth factor or anti-aging claims, the product's Centerville, Mass.-based marketer said. The supplement's name also has been revised from Nature's Youth hGH

You may also be interested in...

“Human Growth Hormone” Supplement Ads Lead NEJM To Contact State AGs

The New England Journal of Medicine has contacted the Massachusetts and New Jersey Attorneys General about the advertising practices of some "human growth hormone" marketers, Editor-in-Chief Jeffrey Drazen, MD, says in a perspective paper titled "Inappropriate Advertising of Dietary Supplements" that appears in the Feb. 27 issue

FDA Warning Letters Increasingly Targeting Internet Claims

More than 80% of the warning letters concerning OTC drug and dietary supplement products sent in the last few months have focused on Internet claims

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts